|

ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

RECRUITINGN/ASponsored by University of California, San Diego
Actively Recruiting
PhaseN/A
SponsorUniversity of California, San Diego
Started2023-11-13
Est. completion2026-12-01
Eligibility
Age25 Years – 64 Years
SexFEMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06128304

Summary

While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to leverage the available infrastructure for HIV care and treatment programs in Nigeria to integrate cervical cancer screening and treatment and conduct a cluster randomized, hybrid type III trial design to assess the comparative effectiveness of a Core set of implementation strategies versus a Core+ (enhanced) set of implementation strategies to implement cervical cancer screening, onsite treatment, referral and referral completion, treatment, and retention in care among WLHIV. The overarching goal is to improve the health and life expectancy of WLHIV with co-occurring cervical cancer.

Eligibility

Age: 25 Years – 64 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Women living with HIV

Exclusion Criteria:

\-

Conditions3

CancerCervical CancerHIV

Locations1 site

UC San Diego
La Jolla, California, 92093
Joella Phillips, BA8589667703jiphillips@ucsd.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.